Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices

被引：0
|
作者：
Bhor, Menaka
Li, Xiaoyan
Favret, Anne
Morrow, Phuong Khanh H.
Denduluri, Neelima
Barron, Richard L.
Saravanan, Shanmugapriya
Girardi, Vincent
Patt, Debra A.
Li, Yanli
Lyman, Gary H.
机构：
[1] McKesson Specialty Hlth, The Woodlands, TX USA
[2] US Oncol Network, The Woodlands, TX USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Virginia Canc Specialists PC, Fairfax, VA USA
[5] US Oncol Network, Fairfax, VA USA
[6] Virginia Canc Specialists PC, Arlington, VA USA
[7] US Oncol Network, Arlington, VA USA
[8] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9606
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9606
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
    Denduluri, Neelima
    Patt, Debra A.
    Wang, Yunfei
    Bhor, Menaka
    Li, Xiaoyan
    Favret, Anne M.
    Morrow, Phuong Khanh
    Barron, Richard L.
    Asmar, Lina
    Saravanan, Shanmugapriya
    Li, Yanli
    Garcia, Jacob
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (11): : 1383 - +
  • [2] Dose delays, dose reductions, and relative dose intensity in early stage breast cancer patients receiving (neo) adjuvant chemotherapy in community oncology practices
    Favret, A. M.
    Li, X.
    Denduluri, N.
    Morrow, P. K.
    Bhor, M.
    Barron, R. L.
    Dhanda, R.
    Langeberg, W. J.
    Saravanan, S.
    Girardi, V.
    Lyman, G. H.
    CANCER RESEARCH, 2013, 73
  • [3] Dose Delays, Dose Reductions, and Relative Total Dose Intensity in Patients With Advanced Cancer Who Exercised During Neoadjuvant Chemotherapy Treatment
    Wonders, Karen Y. Y.
    Schmitz, Kathryn
    Harness, Jay
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [4] DOSE DELAYS, DOSE REDUCTIONS, AND RELATIVE TOTAL DOSE INTENSITY IN PATIENTS WITH ADVANCED CANCER WHO EXERCISED DURING NEOADJUVANT CHEMOTHERAPY TREATMENT
    Wonders, Karen
    Schmitz, Kathryn
    Harness, Jay
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : 44 - 45
  • [5] Dose delays, dose reductions, and relative total dose intensity in patients with advanced cancer who exercised during neoadjuvant chemotherapy treatment
    Wonders, Karen
    Schmitz, Kathryn
    Harness, Jay
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 274 - 275
  • [6] Incidence of Chemotherapy Dose Reductions and Dose Delays, and Reduced Chemotherapy Dose Intensity in Early Stage Breast Cancer.
    Weycker, D.
    Edelsberg, J.
    Kartashov, A.
    Barron, R.
    Lyman, G.
    CANCER RESEARCH, 2011, 71
  • [7] Relative dose intensity reduction in breast cancer adjuvant chemotherapy
    Faustino, C.
    Afonso, N.
    Sousa, B.
    Espirito, Santo J.
    Rodrigues, H.
    CANCER RESEARCH, 2009, 69 (02) : 283S - 284S
  • [8] Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia
    Prakash, Gautham
    Pandrangi, Kelsey
    Khateeb, Ranya
    Jain, Shivi
    BLOOD, 2022, 140 : 11248 - 11249
  • [9] Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
    Martei, Yehoda M.
    Narasimhamurthy, Mohan
    Setlhako, Dipho, I
    Ayane, Gezahen
    Ralefala, Tlotlo
    Chiyapo, Sebathu
    Gross, Robert
    Shulman, Lawrence N.
    Grover, Surbhi
    DeMichele, Angela
    JCO GLOBAL ONCOLOGY, 2022, 8
  • [10] Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy
    Griggs, JJ
    Sorbero, MES
    Stark, AT
    Heininger, SE
    Dick, AW
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 (01) : 21 - 31
12345